Clinical Trial Update: Comparative Study of Palonosetron With Granisetron as a Control in Patients Receiving Highly Emetogenic Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing palonosetron with granisetron for prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogeni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Granisetron (granisetron)
• Palonosetron (palonosetron)

Snippet

Sponsor: Taiho Pharmaceutical Co., Ltd. | Conditions: Chemotherapy-Induced Nausea and Vomiting | Phase 3 | Status: COMPLETED